Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) Operating cash flow

Alert me on Operating cash flow

Abbott Laboratories's operating cash flow for fiscal 2025 was $9.6B, up 11.8% from $8.6B in fiscal 2024. Over the twelve months to 30 June 2026 it was $9.9B. Over the past ten years it has ranged from $3.0B (fiscal 2015) to $10.5B (fiscal 2021); the current reading is higher than 82% of that period. Abbott Laboratories ranks 1st of 149 Medical Devices companies by operating cash flow.

Operating cash flow, annual

Embed this chart

Annual newest first

Period Operating cash flow Change
FY2025 $9.6B 11.78%
FY2024 $8.6B 17.86%
FY2023 $7.3B (24.21%)
FY2022 $9.6B (9.04%)
FY2021 $10.5B 33.31%
FY2020 $7.9B 28.76%
FY2019 $6.1B (2.60%)
FY2018 $6.3B 13.11%
FY2017 $5.6B 73.90%
FY2016 $3.2B 7.99%

Quarterly newest first

Period Operating cash flow Change
Jun 2026 $2.5B 89.20%
Mar 2026 $1.3B (60.33%)
Dec 2025 $3.3B 18.95%
Sep 2025 $2.8B 36.15%
42 more quarters

Against its own ten years

Low $3.0B High $10.5B
Ten-year median $7.3B
Current reading's percentile 82

Operating cash flow against peers

Company Operating cash flow
ABT Abbott Laboratories $9.9B
MDT Medtronic PLC compare $8.0B
SYK Stryker Corporation compare $5.5B
BSX Boston Scientific Corporation compare $4.5B
PHG Koninklijke Philips N.V. compare $2.6B
GEHC GE HealthCare Technologies Inc. compare $2.1B
DXCM DexCom, Inc. compare $1.7B
EW Edwards Lifesciences Corporation compare $1.7B
STE STERIS plc compare $1.3B

What Operating cash flow is

Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.

Reported line item

The full definition of Operating cash flow →

More on ABT